A promising new class of medicines gathers pace The Economist Nawigacja wpisu Editas Medicine Announces Second Quarter 2024 Results and Business Updates – Yahoo Finance From neoadjuvant to organ-sparing immunotherapy for colorectal cancer – Nature.com